Licensed German Medical Cannabis Importer and Wholesaler for Sale

Fully operational, profitable medical cannabis importer and wholesaler with established distribution across Germany. The company is targeting €8.1M revenue in 2025 and projects €10.8M in 2026 (as stated). The platform provides regulatory-compliant market access with an established EU-GDP supply chain, a portfolio of 50+ products across 35+ strains, and a pathway to EU-GMP processing through manufacturing certification currently in progress.

Business Highlights

Revenue and Market Position

• Operating in Germany, Europe’s largest medical cannabis market
• Targeting €8.1M revenue in 2025 and €10.8M in 2026 (stated)

Sourcing and Product Portfolio

• Network of 40 global suppliers for broad-based sourcing (stated)
• 50+ products across 35+ strains, including proprietary brands (stated)

EU-GMP Upside and Margin Expansion

• EU-GMP manufacturing certification in progress (stated)
• Clear pathway to internal processing and manufacturing to capture higher-margin activities

Operational Scalability

• High-volume sales management exceeding 2.5 tonnes annually (stated)
• Lean workforce of 15 FTEs with capacity for increased throughput (stated)

Innovation and Proprietary Advantage

• R&D pipeline includes lozenge formulation access and specialized oral administration concepts (stated)
• Includes access to patented purification technology supporting pharma-grade EU-GMP product supply starting in 2026 (stated)

Investment Opportunity

100% equity sale. Price upon request. Strong fit for global operators, healthcare and pharma groups, or investment firms seeking immediate German market access and a scalable EU growth platform.

‍